E34.322 Insulin-like growth factor-1 (IGF-1) resistance

Instructional Notes:

E34.322
Description: Insulin-like growth factor-1 (IGF-1) resistance
Inclusion Term:
- Genetic syndrome with resistance to insulin-like growth factor-1
- Insulin-like growth factor-1 receptor (IGF-1R) defect
- Post-insulin-like growth factor-1 receptor signaling defect
↓
E34.32
Description: Genetic causes of short stature
↓
E34.3
Description: Short stature due to endocrine disorder
Exclude1:
- achondroplastic short stature (Q77.4)
- hypochondroplastic short stature (Q77.4)
- nutritional short stature (E45)
- pituitary short stature (E23.0)
- progeria (E34.8)
- renal short stature (N25.0)
- Russell-Silver syndrome (Q87.19)
- short-limbed stature with immunodeficiency (D82.2)
- short stature (child) (R62.52)
- short stature in specific dysmorphic syndromes - code to syndrome - see Alphabetical Index
- short stature NOS (R62.52)
↓
E34
Description: Other endocrine disorders
Exclude1:
- pseudohypoparathyroidism (E20.1)
↓
E20-E35
Description: Disorders of other endocrine glands (E20-E35)
Exclude1:
- galactorrhea (N64.3)
- gynecomastia (N62)
↓
E00-E89
Description: Endocrine, nutritional and metabolic diseases
Exclude1:
- transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Notes:
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.